Form 4 Filing for Camp4 Therapeutics Corp

This filing details a transaction by Andrew J. Schwab, a director at Camp4 Therapeutics Corp. On August 27, 2026, Mr. Schwab, through entities associated with 5AM Ventures, disposed of 400,000 shares of common stock at a price of $4.04 per share. The transaction code "S" indicates a sale, and "D" signifies disposition. Following this transaction, the number of shares owned by Mr. Schwab, directly or indirectly through various 5AM entities, is as follows: 2,941,176 shares held by 5AM Ventures VII, L.P., and 302,770 shares held by 5AM Opportunities II, L.P. The filing also notes that Mr. Schwab, as a managing member of the general partners of these entities, may be deemed to have shared voting and investment power, though he disclaims beneficial ownership beyond his pecuniary interest. The total post-transaction shares owned are 2,033,270.